top of page
ayelt-van-veen-h48GcuXklwQ-unsplash.jpg

Media Mentions, Articles, News & Press Releases

Media Mentions

June 19, 2022  -  NPR’s Dog Talk® (and Kitties Too!)

​

“[I’m] so thankful that we have these new products so we can get the diarrhea to resolve more quickly and get the dogs back and the owners happier again sooner.” (49:20)

​

-Dr. Sue Ettinger mentions Canalevia-CA1 on the June 19, 2022 episode #784 of NPR’s Dog Talk® (and Kitties Too!) podcast, hosted by Tracie Hotchner.

Articles

JAGG10621_VPNArticle_SocialPost.jpg

September 2022  -  Veterinary Practice News

​

Why treating CID is so complicated

JAGG10621_PetVetArticle_SocialPost_UXD-008-0922-01.jpg

August 2022  -  PetVet Magazine

​

Navigating the Side Effects of Chemotherapy in Dogs

294667072_3292268237672676_7057064789088990377_n.jpeg

June 2022  -  Veterinary Practice News

​

How 'Going Green' Impacts Veterinarians

News & Press Releases

2022

2021

Contact Us

 

1 (877) 787-3001

info@canalevia.com

  • Instagram
  • Facebook
  • LinkedIn

Location

 

Jaguar Animal Health

200 Pine Street, Suite 600

San Francisco, CA 94104

Home

Contact Us

Resources

Events

About Us

Join Our Mailing List

Investor Relations

Partnering with Canalevia-CA1

Canalevia_byJAG_Logo_White.png

Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.

CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal Law to use this product other than as directed in the labeling.

​

IMPORTANT SAFETY INFORMATION

For oral use in dogs only. Not for use in humans. Keep Canalevia®-CA1 (crofelemer delayed-release tablets) in a secure location out of reach of children and other animals. Consult a physician in case of accidental ingestion by humans. Do not use in dogs that have a known hypersensitivity to crofelemer. Prior to using Canalevia-CA1, rule out infectious etiologies of diarrhea. Canalevia-CA1 is a conditionally approved drug indicated for the treatment of chemotherapy-induced diarrhea in dogs. The most common adverse reactions included decreased appetite, decreased activity, dehydration, abdominal pain, and vomiting.

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Use only as directed. It is a violation of Federal law to use this product other than as directed in the labeling. Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.

bottom of page